Good afternoon, everyone, and thank you for standing by, and welcome to the Corvus Pharmaceuticals Fourth Quarter and Full Year 2025 Business Update and Financial Results Conference Call. [Operator ...

A bone-like composite developed at EPFL uses naturally occurring enzymes to accelerate mineralization through an ...

The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs, today announced new female-specific ...

The announcement is anchored by a study published in Biomacromolecules (American Chemical Society, 2026), conducted by MindWalk in a grant-funded collaboration with Eindhoven University of Technology ...

HT-VA restores cholesterol to control-diet levels and maintains lower triglycerides compared with semaglutide in western diet-fed female mice Treatment preserved hepatic ...

MindWalk Holdings Corp. , a bio-native AI company, today announced B Cell Llamatm, a platform for the discovery of VHH nanobodies: the single-domain antibody fragments increasingly recognized as the ...

Strong capital position of $667.2 million in cash, cash equivalents and short-term investments, together with $180 million in anticipated collaboration payments, expected to support advancement of ...